Evidence map›Paper›PMID 34585055›Full record

ArticleAnnals of gastroenterological surgery2021

Salvage hepatectomy for local recurrence after particle therapy using proton and carbon ion beams for liver cancer.

Motofumi Tanaka, Shohei Komatsu, Masahiro Kido, Hirochika Toyama, Masahiro Tominaga, Yoichiro Uchida, Kazuki Terashima, Yusuke Demizu, Tomoaki Okimoto, Takumi Fukumoto

Open access · goldAbstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Motofumi TanakaDivision of Hepato-Biliary-Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.ORCID https://orcid.org/0000-0002-5286-4965
Shohei KomatsuDivision of Hepato-Biliary-Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.ORCID https://orcid.org/0000-0001-9059-2473
Masahiro KidoDivision of Hepato-Biliary-Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Hirochika ToyamaDivision of Hepato-Biliary-Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Masahiro TominagaDepartment of Gastroenterological Surgery Hyogo Cancer Center Akashi Japan.
Yoichiro UchidaDepartment of Gastroenterological Surgery and Oncology The Tazuke Kofukai Medical Research Institute Kitano Hospital Osaka Japan.ORCID https://orcid.org/0000-0003-2266-7722
Kazuki TerashimaDepartment of Radiology Hyogo Ion Beam Medical Center Tatsuno Japan.
Yusuke DemizuDepartment of Radiology Hyogo Ion Beam Medical Center Tatsuno Japan.
Tomoaki OkimotoDepartment of Radiology Hyogo Ion Beam Medical Center Tatsuno Japan.
Takumi FukumotoDivision of Hepato-Biliary-Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.ORCID https://orcid.org/0000-0003-1592-4524
Kobe University · JPHyogo Ion Beam Medical Center · JPHyogo Prefectural Cancer Center · JPKitano Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWith the increased use of particle therapy for liver cancer, local recurrence after particle therapy increased. Salvage hepatectomy is an acceptable treatment option for local recurrence following particle therapy; however, its safety and effectiveness remain unclear. Therefore, this multi-center study aimed to verify the feasibility and efficacy of salvage hepatectomy and assess clinical issues associated with its application.

methodsWe retrospectively assessed the perioperative outcomes, prognosis, and pathological characteristics of 15 patients who underwent salvage hepatectomy for local recurrence after particle therapy between 2006 and 2019.

resultsHepatocellular carcinoma and metastatic liver tumors were noted in eight and seven patients, respectively. The mean total dose and number of fractions were 66.5 Gy and 12, respectively, and the mean interval between particle therapy and surgery was 30.1 months. Major hepatectomy was performed in seven cases. Moreover, the mortality rate was 0%, and surgical complications of Clavien-Dindo grade IIIa or higher were observed in four cases (27%)-two bile leakages, one pleural effusion, and one refractory skin fistula. The median overall survival time and 5-year overall survival rate after salvage hepatectomy were 29.9 months and 43.1%, respectively. Histological examination of the irradiated liver tissue surrounding the tumor showed sinusoidal dilatation, loss of hepatocyte, and fibrosis in most cases.

conclusionSalvage hepatectomy after particle therapy is a feasible therapy; however, the risk of refractory complications associated with particle therapy is relatively high. Therefore, the first-line treatment for resectable liver cancer should be carefully determined considering second-line treatment after local recurrence.

Indexed as

carbon ion beamhepatocellular carcinomaparticle therapyproton beamsalvage hepatectomy

Identifiers

PMID34585055
PMCPMC8452475
OpenAlexW3163165068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.